Is Altimmune, Inc. (ALT) a Buy, Sell, or Hold?
Altimmune, Inc.
NASDAQ:ALT
$2.93 USD
-$0.06 (-2.01%)
- Volume
- 3.3M
- Average Volume
- 4.41M
- Market Capitalization
- $258.59M
- P/E Ratio
- -3.15
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $6.44
- Year Low
- $2.56
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $29.56
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-70.7% DOWNSIDE
$10.00 Price Target
UPSIDE/DOWNSIDE HIGH
-85.4% DOWNSIDE
$20.00 Price Target High
UPSIDE/DOWNSIDE LOW
17.2% UPSIDE
$2.50 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Leerink Partners | Thomas Smith | $10 | $3.005 | 2026-06-22 06:30 AM | 232.8% |
| Goldman Sachs | Corinne Johnson | $2.5 | $2.89 | 2026-04-24 05:10 AM | -13.5% |
| H.C. Wainwright | Patrick Trucchio | $12 | $10.23 | 2024-04-02 02:42 AM | 17.3% |
| Piper Sandler | Yasmeen Rahimi | $25 | $18.94 | 2022-08-30 04:40 PM | 32.0% |